JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?j(s\5c@EQܚQԬ7Prp>ڼV`ݒ R+׵_U¢ۃB==YycXʧDzTpi+߱OXjPnM>?|[lˊV??nsNha=bP=@gx*='JU=sN1g;5:vkYue:O>Grq#Z%熯~bKBb~YoCZFr @?Ηd|8\]_ ЗAW\}5_+!hl`I7cksZM|O(QFz}? IߊzއpkP";ʷ\x'U+Tt/A:C}JH((@xDX8<ɠj.[Y5ȷ•>&lhsOշ㭢h c+k'تNn-hŢ(?λI-c9Xģl~^_fh׸B+Z&?3fYTvVGv ܟA#"jSsXV)N-8=U@;t?*Tڥ}@Cs|%Hu{˅$.^}A䠹:uale|֧%&R9׬jGo# 9ckmp`:I>yak[E Vg#kr0zzWڊJm)fU8,{c^yicw{1H]j=^MKDyĀ\Cekث i/1塎!ov`F}S^VbQE%s$񅗇Slv+qOaTe;VpHȉ}y=,#$/#6KZʥE݅5+$zyPP~a{Җ W'ZO,0˒OW3z؅(SV ʽXlnBx`sOڀ mRзr'$2|=S`ݨYdo ej ʒ $zթ5JQ${k ya(&ةhƿsj9?Q+5Z=\+GTz6u&c8&HxJY=V5$}[nG0ᢂ_SE]Ѿ^/A|)ON{ArqXΝemr,-*; 9oYECi}h18ypHrcq |y3⍜弰y>z-%fpbhTUJ;~FƗ;K ~l;k奦<b>k9RHF98q/]m٭L O5Ah|䳻vXSc;ͮTE.Ic.$6b۵fA[+پe)̣N3AbGlC!JoxPIq o)<޽Sӭ);;җ?4_CsL1$P~j:vV4W? M0=@0??ZꩡrE:Nay4-^HS?yu5x5)U$R? *'.TtaC [iI%۩5T䝫ǩ?V&T(&wv} I+!@\(N 3M4'Ґǥҁ1i y;O4CB0oȸHKS2&y21܎+ sQM45-1!xսٞ.aA =H);e>ӆ s]Ї`@gzF? NsP6Y5uH/cQ'~xWsEi] 4')#kB&mttp8;ҳ{JӪ&5Ɵlnաyc%=:ryJ5kG8Ҽ/>%`D92(FҲ!>{,}?*/G9yRv<\K\MrҌ#1\uM"Up:1Vo5"6߼} êTZsgi( 0M]-#cķJeS@긯^i9yo\ƷokŤemØ#V!v_ųŢ\~Vik$U,k#]4-.?5T F~n'ڸ{_N}8?&pF C2%'ґ]$GV!mqiiݱE4 u}}$_(fzHhͣ(93O"-\7c^mx^2ۭ#8>{e qU)h>q)mܤ\ê ~bmey|ЬGp+譊zPG]Οo ឫ0}UmRV~+&zSEg j]vOsZyZ 6 \ZF q|=ėw3M)wlpY?L~PLvS&?w A1;3`=(Vrc׏JNLqJQrAx;'Qռ~27g%HK()oʷm}Le%Fk>q5 ͼuEtv4.(vDw2DG4P4 F>;uaI-"(cqqz'WI{$T QWR%*(<Т((_C5S%O++եvZJi:~bkhOң#N=G'9>rO5鐥Ae .cTWQ/ X.G'إ #~=ZlĊE@f 2## ʁM0N sJ@ɦd~t$tgqD;z?( r9*N@KN^G e== VqM'̠wN+@8'֦[ec m\\O*,#4R'm]]N G@ÁUk ʻÑ'C*Đ]Yjgx, .!TF[*PO^v3!#N(I '%&N3V4dq @ <!?g#яO( ( ( w w\8Nb< (ἱr4vbk2 T0fGCWxcK5Ò. xlzN2Gjf[K[Wrd ;řqR.no­ۿ@GT #'5$Ue 1=jpҚ˴yqJO-mpp!(lcs/[2,Ȏva/Q:$Oj_ц o0vS/Ua{TC+Qm&V9joH=)3H xP1œh@cJ'!x8W4MĚ,U_ӑĿ m9 Exn_*̥lm\=ĝ7A>Hجlq$&U&u't(9((+'V.:mn@ݱn#z€+x)φ'tKhїMqױ\t+yV ڍad$;֗]Omgku A'We{iXDb[wVa%xçjMV*u-:շϔ܂=WU_4 Am_`blo\ϯ5>=4t[;eLOkҌZ&7|IhL&I:FI>]y#x$XNތqdzӲ@O@j21cYGR  Ri5f5&?4YsOAHqzge;m1d'+]խol;`qad'' NctLJJ7Ԟ+;3b:eu[\V1ׯ.5QXFZ w{oc xui(;_zyi;g#m``u52=yi R O|]YǎjX:c2Ըd) ((((ώ:H ć>+̏>2i_o;ܨ%I${?|zڮ/@ׯ|X=k* s^C^[TmKstc(luڻ$#ԼQ imw|cPޑQnnuJHO~" y5 숣;(JqĞ烎&##'P Pt1cK+h䓀>[[-(}dpH ))CJ5g[Y.O?Jx'Q/.P.(t#֐dX`ǵ1;t@?M4\7 wu?6#ZO`=(QEQEQEQERլT.e$%- 1_&o2du=|?FO/¨XNzjkp8+>KHa}4y#usmO)|kii9?g[i6T` r$Y䳺uİ;DЃ?Jf;U^&VIhڎl h>?βA8G됞-=LT"AGJUl2HݱYr9OP32,qTɑN.=N*vB3v3SAN{PfgE~U$Q T?¹Kfg]`ڻOqiNT=r((((((JڴM^5)?}WV/4ۛM@4̨3 ?Bv`|*+O>5luKmo_A?^+GCOe]VS{u"gb2z6My/K"XX\&{c}n[׬u҆/YeH66IגӋ bC=j儆;.|ؚ2> 3g9#2J?_ZFTPA+#"r8 [.F: LiRG \yǵ:6~n @E>fzg!B{71^!g8u,DE!#Iv 9F|(UmS\kH́Tdv [פ$$'/`GQE ( ( ( (eLlk3I3cAހ=G\`6IJ8xS\ve)"f`ITo|cWxSצ}:G>ykKyιyvmOqux⎃Z^Gcr2NvRN0}3s=*Pӭ- =zv#_"P]>F^ OϰkX1Hն'AX:>XLܑzek`TSo:u݌7_@fW&ᨴoG[jA n?A戲b=I,9ǧ=NyX(o 6AJ;cCTuFS8#ԸfC#͓"8p4Pg!I#9j`e,xs烊nnD}~M\ؼ^?9x,\FHƻ5ZPW;'$G'ˮAhFAjRQEf0(((maFdiό;U(gIzrAǁ+ЪGth[ ޕI9;Iye>y5MGR9T*9<·m&bb1%żY$;fu-*EՎC\FcȽOpko#xQ %Ł /xVzԤwCp牽GS{1?EnXJOJ.'bP;t+ ڙ3j3 cy<^CZivAϙ(>l0xV۩t۫'=?G3xw7%P\!LE0n5 &e\5zd>U a*&jnEQEQEQEQEQEQERR$zivRs>΀9>ҼGzo.m,ơHr2G+ b?>5 ˊ1 N:صFE2FY,6,rz:੭/,xLj-s>\󀣧#OQKa]A_ EEﳕf+$=5(}& "Y=FFqWu6{M> D),APzWYR<Z k4#?F#) (((((((((M:I,a*u'#'"+xĖ>̊vCndn{V6ͩ.8R3I;^EcDJi.&9ڱO>,䠈ۭFbUd%q\?rxw\"1au;[s+}kw^\2w~zBE51IY T0$i>bIudMC4>e?9?}r=^3Jv} Yv459K(!N8m:]|1-m~s{~mA[F?yZZ( ( ( ( ( ( ( ( ( xD$=Pm֗"cZœ:c#;0|DP0NEts .nm嶷tDN nʎ5$F1.5 2b<Kj"+*(c{Y-ZCl}֍Vu)HyOZmd:GXӥ"V~Oj6ڼv kge$WOz=I4`%P{`PYMj kˋT|ө=èmpAHb,?6~*DXp?)CLRvbqMIc,hrⱪ)ϮzT. ,^s.(=(wDE [""gvA1[Q[ƆIAcӎ;;I+*$awHO;{<9bD-!* ϷLzԹѯ/5†1f-)W7ֲֺog9)ɏz8O`>`ҵW01 OSsٷ|#8 ?.OT.4wv!9=hXͰY- WAmI䌁&)^bxTM4$yБK z2eVeP0qO\r '=sJj`NE0a(hIGZps*ed*pwRu$sM,@1=9$29I9M\r99緥PDYm<9tdF@PA-@`IE7b Ppfp lXs*hA9} '<=p#㩭q<:<z{A"3)~=zU #"I$c)j2Y(\AO[42} Q?Z5)F5Y4[I{) $k<' V-K VG{?~\ZCim~1Z*8`# =+SP$gE%~)bmS>t #1]~DS=C mNvfyAUV2G`0I.@OjNWt4$uP"  ={TνFH~#1L29OH=x&HCXM1 ǥA(Qϸqr#>x*<jew@dX.Yu*w=;pdL/$3~jZ. +M}),wC-ylA ښ&AAcx]R13ޜ :7f;A#֘,6lgirpޕNTVozN~0r:T)$6sҜe p\T %(_u)N0:sޘi'4RH9B:)'wM19@`P:%~( @hD}qЊ) {QN¹give cash incentives to their players for working out, or do they pretty much work out hard on their own anyway?<br>Adams: We don t construct our contracts in such a manner that they get incentives. They do get a per diem for being in the program, but it s insignificant compared to what they normally make.<br><br>BFS: Do you do any special testing on your players?<br>Adams: Yes and no. I do an assessment on all the players, but it s very visual and is accomplished by watching them move and do things. There are a few individuals who have certain issues, and I ll actually assess them on a table, but from a testing perspective it s not like I run 40s with them. There are certain lifts that I want to know how much they can do, but nothing other than that.<br><br>BFS: Is the NFL combine a valuable tool for pro coaches?<br>Adams: I personally am not a big fan of the combine I think it s an archaic test. The one thing the combine does have is a history, and it can tell us if a college kid can run. If an athlete can run, then there is hope that he ll eventually be a great player. The only time we test the 40 is when we bring in a free agent, but other than that it s all about game speed and the play on the field. <br><br>BFS: What are the most common injuries you re seeing with football?<br>Adams: It s hard to put a number on what would be the most prominent injuries. We see concussions and a lot of soft tissue injuries, but there isn t a part of the body that is exempt from being injured in football. It s a total contact sport.<br><br>BFS: Do the pro athletes you work with eat well?<br>Adams: You would think so, but in actuality that s not necessarily the case. <br><br>BFS: What is your philosophy about nutritional supplements?<br>Adams: I come from the perspective that athletes need to eat well before they even think about supplementation. We do provide some supplements to our athletes, but the NFL has created some very strict and stringent guidelines on what can and cannot be taken. We ve really taken a step back from a supplementation perspective because the last thing we want to do is recommend something that might flag in a test as a banned substance. We have to be very cautious to be sure that the supplement companies we recommend do not produce any products in their line that has anything with ephedrine or with any androgenic or anabolic substances. That limits the number of companies to a very, very small number.<br><br>BFS: When was the last time you worked 40 houF(j;2ò1tr6Apķ~n36<["B^1TMpU^3{=Ũq;:PvZ,g3J6ِg\AqȻꓦ.񩮍K)8M 8s1Ro}ȭq798۵dJ'P?~'38&Z :HиH_mAͷk%Ub`23dA6ةd:"L14C2;pɂH9sɒ+֤3nY%$9Ubz(Km8/ MNhճcW%ȑZ`:ov\ *r l$`FжVHgڭc՝#nH)!@*|<73a7[4k2}5qTo0x,@Z. ={ȣ.+!v$P)fvɠqO+YpQ*{ 9Y_Ǽ:ڃҭB-6缚k]PXͣg"5ڕqOɹjrGyYb.GnoԘx3$GW~`Is& 8Mڹ@#9UsoޭF>*əDv(uX.QTƖnp/̃)̤ᴇx #qd-db[,"LSW;Ppt͛؅j81R|]Ga9?.}Ϝ>h6qu#bo8Jn(bCTƍ[<я4㎘&* R9&puP8@#MQUSFoM*1lu]K{ hH gaUYjhz#6.8B-u_fپXK6cҖl@CW/͹/X yu櫄Jqse/Uv juV _:m\|j~ETET^r=s|7Jy,kQyzt_8 FLq4/)odVۙ#[ھvUW pqD,2#)ε *[e.$%{ݮlq6Wm 8.&- | [e6ݼfD5TxQ]u ٸ d\ v.ٽI 45'mh%㦈T~sU͙cRs1 n"GS6b91uTs=MQR{dWзխrR'-j9~͗N2H,@TMIs}ag/cxī3Ƭ.n.AcR98Zfk57& wC(AeN^w{Bu'xX qr$D$Jfoœ2Ade"e2[Q}ю